The aim of the present study was to identify the role of miRNAs in end-stage renal disease (ESRD) patients with CKD-MBD and to elucidate possible links between miRNAs and the traditional bone turnover serum marker PTH. This evidence concerns the gene PTH and chronic kidney disease.